Zentiva Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-08-22
Share capital
132 097 500,00 PLN
Activity description

Zentiva Polska is a partner to patients, healthcare professionals and the healthcare system. The company develops, manufactures and supplies high-quality, affordable medicines, reaching over 100 million people in more than 40 European countries.

Registered address
ul. Bonifraterska 17, 00-203 Warszawa, Poland
Website
zentiva.plWebsite active
Social media
Electronic delivery address
AE:PL-32813-26064-RUFJG-31

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 134.30mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 2.14mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 127.31mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 77.64mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2017-09-04. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 19,095

Secured liabilities

Type
Registered pledge
Financial pledge

MSiG notices

Publication dateEvent
Feb 14, 2022Merger registered
Feb 14, 2022Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Hacho Agop Hatchikian – President of the Management Board
Joanna Flisiuk – Vice President of the Management Board
Joanna Kawecka – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Zentiva Pharma Gmbh
2,641,950$35,682,739.06100%

Beneficial owners

Person

Competitors

Name
Sanofisp. z o.o.
Novartis Polandsp. z o.o.
USP Zdrowiesp. z o.o.
Pfizer Trading Polskasp. z o.o.
Natur Produkt Zdrovitsp. z o.o.
Bialmedsp. z o.o.
Roche Diagnostics Polskasp. z o.o.
Servier Polska Servicessp. z o.o.
Medezinsp. z o.o.
Magnapharm Polandsp. z o.o.

Change history

DateEvent
2018-07-02Share capital change
2018-04-27Address change
2018-04-17Share capital change
2018-03-13Address change
2018-03-13Name change

FAQ

Last updated: 2026-10-04